VivaZome Therapeutics Pty Ltd and ToolGen, Inc. extend collaboration agreement based on successful proof-of-concept outcomes
22 April 2020 Melbourne, Australia and Seoul, South Korea: VivaZome Therapeutics Pty Ltd (“VivaZome”) and ToolGen, Inc (“ToolGen”) have announced the extension of a collaborative research project exploring the gene-editing of cells for enhanced exosome production. Under the…
Bosch Australia’s Manufacturing Solutions business unit awarded COVID-19 project by Grey Innovation
21 April 2020 Bosch Australia’s Manufacturing Solutions division (BAMS) has been awarded a AUD $1 million project as part of the industry consortium to build ventilators in Victoria. The notus Emergency Invasive Ventilator Program, a Grey Innovation led…
Clinical trial into two potential COVID-19 treatments commences
21 April 2020 A clinical trial aimed at testing the effectiveness and safety of two existing drugs in patients hospitalised with COVID-19 has opened at the first site, The Royal Melbourne Hospital. Led by Associate Professor Steven Tong, a Royal…
Victoria’s coronavirus (COVID-19) modelling confirms staying at home saves lives
20 April 2020 The Victorian Government has released modelling to provide greater understanding of the spread of coronavirus in Victoria. The modelling, done by Victoria’s epidemiological experts at the Department of Health and Human Services and in collaboration…
Partnership To Revolutionise Cancer Diagnosis
21 April 2020 Medical technology company Sienna Cancer Diagnostics has partnered with The University of Adelaide in an exclusive worldwide licencing agreement to develop a unique cancer probe with the potential to detect a sugar molecule only present…
CSIRO unlocks new way to understand evolving strains of SARS-CoV-2
20 April 2020 Researchers from CSIRO, Australia’s national science agency, have unveiled a new approach to analysing the genetic codes – or the blueprint – of the SARS-CoV-2 virus that causes COVID-19. The findings will help researchers better…
Stepping up to shield our healthcare workers from infection
16 April 2020 RMIT engineers are 3D printing face shields for frontline healthcare workers in a rapid response to projected shortages during the pandemic. A team at the university’s Advanced Manufacturing Precinct (AMP) have so far made 950 prototype face…
Starpharma (ASX:SPL) compound shows activity against coronavirus
15 April 2020 Starpharma’s antiviral dendrimer, SPL7013, has been shown to have significant activity against SARS-CoV-2[1] (coronavirus), which causes COVID-19 SPL7013 is the active component in Starpharma’s range of marketed VivaGel® products[2] (VivaGel® BV and the VivaGel® condom), already sold in Australia, UK, Europe,…
PharmAust and Walter and Eliza Hall Institute to Evaluate Monepantel on COVID-19 Infection Model
17 April 2020 PharmAust has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research in Melbourne, Victoria (“WEHI”). Under the Agreement, PharmAust will provide both monepantel and monepantel sulfone to WEHI,…
Our wicked problem and the pursuit of a new normal
16 April 2020 Ms Gouri Betigeri, Country Manager ANZ, Life Science, Clarivate On 30 March 2020, Prime Minister Scott Morrison announced that the Commonwealth Government will roll out a $130 billion wage subsidy program, called the JobKeeper Payment…
Australian Medtech Startup Made It To The Finals In The World’s Largest COVID-19 Hackathon
16 April 2020 ‘3 Billion People in Lockdown. Let’s Hack The Future and Never Go Through This Again’ – the slogan of a world renowned online hackathon called ‘The Global Hack’. MedTech Startup MUVi made it into the…
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
15 April 2020 Sanofi and GSK today announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address…
